Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Sell
50
XBI Quote, Financials, Valuation and Earnings
Last price:
$79.09
Seasonality move
:
7.9%
Day range:
$79.02 - $81.17
52-week range:
$66.66 - $105.47
Dividend yield:
0.17%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
14.6M
Avg. volume:
12.4M
1-year change:
-6.6%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
$79.10 | -- | -- | -- | $0.01 | 0.17% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$55.97 | -- | -- | -- | $0.00 | 0% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$39.87 | -- | -- | -- | $0.01 | 0.25% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$38.16 | -- | -- | -- | $0.03 | 0.07% | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
$28.02 | -- | -- | -- | $1.17 | 4.19% | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
$77.17 | -- | -- | -- | $0.03 | 0.04% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.674 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.324 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 1.638 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 1.514 | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | 1.418 | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.595 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
SBIO
ALPS Medical Breakthroughs ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
SPDR S&P Biotech ETF vs. Competitors
-
Which has Higher Returns XBI or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About XBI or BBP?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe SPDR S&P Biotech ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is XBI or BBP More Risky?
SPDR S&P Biotech ETF has a beta of 1.057, which suggesting that the stock is 5.707% more volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.686, suggesting its less volatile than the S&P 500 by 31.442%.
-
Which is a Better Dividend Stock XBI or BBP?
SPDR S&P Biotech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.17%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or BBP?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns XBI or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About XBI or PSCH?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe SPDR S&P Biotech ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is XBI or PSCH More Risky?
SPDR S&P Biotech ETF has a beta of 1.057, which suggesting that the stock is 5.707% more volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 1.009, suggesting its more volatile than the S&P 500 by 0.85900000000001%.
-
Which is a Better Dividend Stock XBI or PSCH?
SPDR S&P Biotech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.17%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.25% to investors and pays a quarterly dividend of $0.01 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or PSCH?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns XBI or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About XBI or PTH?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe SPDR S&P Biotech ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is XBI or PTH More Risky?
SPDR S&P Biotech ETF has a beta of 1.057, which suggesting that the stock is 5.707% more volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.970, suggesting its less volatile than the S&P 500 by 2.963%.
-
Which is a Better Dividend Stock XBI or PTH?
SPDR S&P Biotech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.17%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or PTH?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns XBI or SBIO?
ALPS Medical Breakthroughs ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat ALPS Medical Breakthroughs ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- -
What do Analysts Say About XBI or SBIO?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ALPS Medical Breakthroughs ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than ALPS Medical Breakthroughs ETF, analysts believe SPDR S&P Biotech ETF is more attractive than ALPS Medical Breakthroughs ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 SBIOALPS Medical Breakthroughs ETF0 0 0 -
Is XBI or SBIO More Risky?
SPDR S&P Biotech ETF has a beta of 1.057, which suggesting that the stock is 5.707% more volatile than S&P 500. In comparison ALPS Medical Breakthroughs ETF has a beta of 0.904, suggesting its less volatile than the S&P 500 by 9.647%.
-
Which is a Better Dividend Stock XBI or SBIO?
SPDR S&P Biotech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.17%. ALPS Medical Breakthroughs ETF offers a yield of 4.19% to investors and pays a quarterly dividend of $1.17 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. ALPS Medical Breakthroughs ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or SBIO?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than ALPS Medical Breakthroughs ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than ALPS Medical Breakthroughs ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while ALPS Medical Breakthroughs ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for ALPS Medical Breakthroughs ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- SBIOALPS Medical Breakthroughs ETF-- -- -- --
-
Which has Higher Returns XBI or XHE?
SPDR S&P Health Care Equipment ETF has a net margin of -- compared to SPDR S&P Biotech ETF's net margin of --. SPDR S&P Biotech ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBISPDR S&P Biotech ETF-- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About XBI or XHE?
SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Biotech ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe SPDR S&P Biotech ETF is more attractive than SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBISPDR S&P Biotech ETF0 0 0 XHESPDR S&P Health Care Equipment ETF0 0 0 -
Is XBI or XHE More Risky?
SPDR S&P Biotech ETF has a beta of 1.057, which suggesting that the stock is 5.707% more volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.111, suggesting its more volatile than the S&P 500 by 11.072%.
-
Which is a Better Dividend Stock XBI or XHE?
SPDR S&P Biotech ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.17%. SPDR S&P Health Care Equipment ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Biotech ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHE?
SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. SPDR S&P Biotech ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, SPDR S&P Biotech ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Biotech ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBISPDR S&P Biotech ETF-- -- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
49
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Buy
71
PEGA alert for Apr 24
Pegasystems [PEGA] is up 28.8% over the past day.
Buy
67
SMMT alert for Apr 24
Summit Therapeutics [SMMT] is up 21.57% over the past day.
Sell
36
ENPH alert for Apr 24
Enphase Energy [ENPH] is down 15.59% over the past day.
